Here are the DEF 14A proxy statements from Option Care Health, Inc. (OPCH) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow OPCH and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full OPCH filings page.
Option Care Health is asking stockholders at its 2026 virtual annual meeting to elect nine directors, ratify KPMG as independent auditor for 2026, and approve executive compensation on an advisory basis.
For 2025, the company reports net revenue of $5,649.5 million, up 13.0%, net income of $207.6 million, adjusted EBITDA of $471.3 million (up 6.2%), and adjusted EPS of $1.72 (up 8.9%). Cash provided by operating activities was $258.4 million. Management notes more than 2.5 million infusion events for over 315,000 patients, supported by about 8,000 team members.
The proxy emphasizes governance features such as one-share/one-vote, an independent board chair, annual director elections, proxy access, and stockholder-called special meetings at 25% ownership. Executive pay is heavily performance-based, with more than 85% of target CEO compensation tied to financial and stock performance, using annual incentives and PSU/RSU grants under robust ownership and clawback policies.